Bridgepoint Group plc Director Declaration

RNS Number : 6375U

Bridgepoint Group plc

01 July 2024

 

Bridgepoint Group plc
("Bridgepoint" or the "Company")

 

Director Declaration

In accordance with Listing Rule 9.6.14R, the Company advises that Cyrus Taraporevala, an Independent Non-Executive Director, has been appointed as a Non-Executive Director of Pfizer Inc.

ENQUIRIES:

 

Bridgepoint

 

Analysts and investors Adam Key [e-mail] [phone]

Media Christian Jones / James Murray [e-mail] [e-mail] [phone]

 

FGS Global (Public Relations Adviser to Bridgepoint)

 

Charles O'Brien / [phone] / [phone]

 

Anjali Unnikrishnan / [phone] / [phone]

 

[e-mail] 

 

Legal Entity Identifier (LEI): 213800KFNMVI8PDZX472

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

RDNZZGGNZMRGDZM